Table 3.

Summary of levels of growth inhibition of representative yeast pathogens by MRC inhibitors: agar plate-based yeast dilution bioassays. ^a

MRC components targeted	MRC inhibitors applied	C. neoformans 90112	C. gatti MYA-4560	C. albicans 90028	C. glabrata 90030	C. krusei 6258
	None	6	6	6	6	6
I	Rotenone	3	4	6	6	6
II	Carboxin	5	6	6	6	6
	TTFA	6	6	6	6	6
	3-NPA	6	6	6	6	6
AOX	BHAM	6	6	6	6	6
	SHAM	6	6	6	6	6
III	AntA	4	6	6	6	6
	Kre-Me	3	5	6	6	6
	PCS	3	4	6	6	6
	AZS	4	6	6	6	6
IV	KCN	6	6	6	6	6
	Na-azide	3	4	6	6	6

^a.TTFA, Thenoyltrifluoroacetone; 3-NPA, 3-Nitropropionic acid; BHAM, Benzhydroxamic acid; SHAM, Salicylhydroxamic acid; AntA, Antimycin A; Kre-Me, Kresoxim methyl; PCS, Pyraclostrobin; AZS, Azoxystrobin; KCN, Potassium cyanide; Na-azide, Sodium azide. Numbers represented highest dilution level (log₁₀) where cell growth was visible. Numbers in bold show cell growth was inhibited (viz., < 6).